Recombinant Collagen IV anticorps

N° du produit ABIN7880477

Cet anticorps Lapin Monoclonal détecte spécifiquement Collagen IV dans IHC (p). Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour Recombinant Collagen IV anticorps (ABIN7880477)

Antigène: Collagen IV (COL4) (Collagen, Type IV (COL4))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp Collagen IV est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: COL4-4241R

Détail du produit anti-Collagen IV anticorps

Fonction: Recombinant Collagen IV Antibody / COL4A (azide and preservative free)

Purification: Protein A affinity chromatography

Immunogène: Purified human placental extract was used as the immunogen for the Collagen IV antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the recombinant Collagen IV antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the recombinant Collagen IV antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur Collagen IV

Antigène: Collagen IV (COL4) (Collagen, Type IV (COL4))

Autre désignation: Collagen IV

Sujet: Collagen Type IV is a major component of the basement membrane and plays an important role in cell adhesion, migration, differentiation and growth. Collagen Type IV express at the basement membranes in a variety of tissues including kidney, muscle, lymph nodes, lung, tendon and spleen. Collagen Type IV has been shown to be useful in differentiating microinvasive from in situ ductal carcinomas of the breast. Other Collagen Type IV studies include use in pancreatic adenocarcinoma and chronic pancreatitis, nephrosclerosis and other kidney diseases, oral squamous cell carcinoma, laryngeal cancers, ovarian cancers and cervical cancers.

UniProt: P02462